Top news
The great vaccine robbery: Pharmaceutical corporations charge excessive prices for COVID-19 vaccines while rich ...
Israel to start vaccinating kids aged 5-11 who have severe background illnesses
FDA asks Pfizer, Moderna to test their vaccines in more children to help rule out safety issues
By Laurie McGinley, Carolyn Johnson & Yasmeen Abutaleb
All coverage
EXCLUSIVE AstraZeneca exploring options for COVID-19 vaccine business - executive
By Pushkala Aripaka & Alistair Smout
Efficacy of Pfizer/BioNTech Covid vaccine slips to 84% after six months, data show
By Matthew Herper & Damian Garde
Moderna says it plans to expand Covid vaccine trial for kids 5 to 11, will seek FDA OK as early as year-end
By Berkeley Lovelace & Berkeley Lovelace Jr.
Pfizer Revenue Boosted by Covid-19 Drugs
By Felix Richter
Coronavirus Updates: Covid-19: C.D.C. Reverses Testing Advice for Fully Vaccinated (Published 2021)
By Apoorva Mandavilli, Reed Abelson & Dan Levin
Why Hasn't The FDA Fully Approved Any Covid-19 Vaccines Yet?
By Katie Jennings
AstraZeneca Loses Money on Covid-19 Vaccine for Second Straight Quarter
By Cecilia Butini & Jenny Strasburg
Pfizer data suggest third dose of Covid-19 vaccine 'strongly' boosts protection against Delta variant
By Jacqueline Howard
Pfizer now expects COVID vaccine sales to reach $33.5B this year, a whopping $7.5B bump from its estimate 3 months ...
By Kevin Dunleavy
Pfizer's CEO says Covid vaccine effectiveness drops to 84% after six months
By Kevin Stankiewicz
Citing New Data, Pfizer Outlines Case for Booster Shots (Published 2021)
By Apoorva Mandavilli, Sharon LaFraniere & Carl Zimmer
Vaccine Makers Are Asked to Expand Safety Studies on Children (Published 2021)
By Sharon LaFraniere, Noah Mercer Weiland & Sheryl Gay Stolberg
Pfizer and Moderna Are Expanding Vaccine Studies of Kids 5 to 11
By Sharon LaFraniere, Noah Mercer Weiland & Sheryl Gay Stolberg